Biosound signs deal with Summit

Article

Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced

Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced Ultrasonography (AU) line of scanners. Summit will sell the units to radiologists, medical imaging centers, and breast imaging centers, while Biosound's sales force will continue to sell the system to remaining markets, including cardiology, vascular and general surgery, and neurology.

The most recent system in the AU family is AU5, introduced last year and cleared by the Food and Drug Administration this September (SCAN 9/17/97). Biosound hopes the deal with Summit Medical will give it increased access to the multispecialty radiology market and the women's health market.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.